View image on Twitter

Congratulations Paul Myles, ANZCA CTN. ATACAS - ACTA Australian clinical trial of the year. 

Feature article:

New research shows the medication tranexamic acid (TXA) could nearly halve the number of people who suffer complications with bleeding following open heart and other major surgery.

  • CCS blog story, "Major surgery outcomes improved with TXA"
  • Journal reference: Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S; ATACAS Investigators of the ANZCA Clinical Trials Network. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. N Engl J Med. 2016 Oct 23. [Epub ahead of print] DOI: 10.1056/NEJMoa1606424

Research publications